Low Back Pain and Antibiotic Treatment
Primary Purpose
Low Back Pain
Status
Withdrawn
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
Antibiotics
Sponsored by
About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring low back pain
Eligibility Criteria
Inclusion Criteria: - Must be able to swallow tablets Exclusion Criteria: - Allergy to antibiotics
Sites / Locations
Outcomes
Primary Outcome Measures
protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation
Secondary Outcome Measures
Full Information
NCT ID
NCT00285493
First Posted
February 1, 2006
Last Updated
March 12, 2014
Sponsor
Loewenstein Hospital
Collaborators
Clalit Health Services
1. Study Identification
Unique Protocol Identification Number
NCT00285493
Brief Title
Low Back Pain and Antibiotic Treatment
Official Title
Phase 1 Study of Antibiotic Treatment for Low Back Pain
Study Type
Interventional
2. Study Status
Record Verification Date
June 2011
Overall Recruitment Status
Withdrawn
Why Stopped
Withdrawn: study halted prematurely, prior to enrollment of first participant
Study Start Date
January 2006 (undefined)
Primary Completion Date
February 2006 (Actual)
Study Completion Date
February 2006 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Loewenstein Hospital
Collaborators
Clalit Health Services
4. Oversight
5. Study Description
Brief Summary
Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.
Detailed Description
Clinical trial using antibiotic treatment, namely Rulid, after onset of low back pain.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
low back pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Antibiotics
Primary Outcome Measure Information:
Title
protocol designed to assess or examine persons or groups in a systematic way to identify specific markers for eligibility for further evaluation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Must be able to swallow tablets
Exclusion Criteria:
- Allergy to antibiotics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bambi Alyagon, MSc
Organizational Affiliation
Loewenstein Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Shoshana Weiler, MD
Organizational Affiliation
Loewenstein Hospital
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Low Back Pain and Antibiotic Treatment
We'll reach out to this number within 24 hrs